Skip to main content

Table 7 Distribution of first events by treatment modality: CCLG patients

From: Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92

 

Local treatment modality, N (%)

Total

Surgery alone

N = 70

RT alone

N = 81

RT then surgery

N = 6

Surgery then RT

N = 32

None

N = 18

Unknown

N = 3

No event

41 (59)

31 (38)

2 (33)

14 (44)

0

2 (67)

90

Local recurrence

5 (7.1)

12 (15)

1 (17)

1 (3.1)

10 (56)

0

29

Distant recurrence

18 (26)

28 (35)

1 (17)

13 (41)

5 (28)

1 (33)

66

Local and distant

3 (4.3)

6 (7.4)

2 (33)

3 (9.4)

2 (11)

0

13

Relapse-unspecified

0

0

0

0

0

0

0

Second malignancy

1 (1.4)

1 (1.2)

0

0

0

0

2

Death—no relapse

2 (2.9)

3 (3.7)

0

1 (3.1)

1 (5.6)

0

7

All deaths

24 (34)

45 (56)

4 (67)

15 (47)

16 (89)

1 (33)

105

  1. RT radiotherapy